Loading...

Reese Jones, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentPsychiatry
Address401 Parnassus Ave, LangPorter
San Francisco CA 94143
Phone415-476-7452
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    Pharmacokinetic and Pharmacodynamic Studies for Medications Developmen-27108807
    NIH/NIDA N01DA008807Sep 30, 2000 - Sep 29, 2003
    Role: Co-Principal Investigator
    Drug Dependence Clinical Research Program
    NIH/NIDA P30DA012393Sep 1, 1999 - Jun 30, 2020
    Role: Co-Principal Investigator
    PHARMACOKINETICS OF DRUGS OF ABUSE IN SKIN AND HAIR
    NIH/NIDA R01DA010781Apr 1, 1998 - Dec 31, 2001
    Role: Principal Investigator
    PHARMACOTHERAPY OF COCAINE ADDICTION
    NIH/NIDA U19DA010939May 1, 1997 - Dec 31, 2002
    Role: Principal Investigator
    PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES
    NIH/NIDA N01DA048306Jun 30, 1994 - Aug 31, 2000
    Role: Principal Investigator
    PHARMACOKINETICS OF PSYCHOACTIVE DRUGS
    NIH/NIDA N01DA007307Sep 28, 1990 - Dec 27, 1993
    Role: Principal Investigator
    COCAINE DEPENDENCE AND TOLERANCE
    NIH/NIDA R01DA004419Apr 1, 1987 - Dec 31, 1991
    Role: Principal Investigator
    MARIJUANA SMOKING TYPOGRAPHY AND DOSE REGULATION
    NIH/NIDA R01DA003473May 1, 1984 - Oct 31, 1987
    Role: Principal Investigator
    EFFECTS OF THC TOLERANCE-DEPENDENCE ON MARIJUANA SMOKING
    NIH/NIDA R01DA003155Apr 1, 1984 - Mar 31, 1987
    Role: Principal Investigator
    COCAINE PHARMACOKINETICS AND PHARMACODYNAMICS
    NIH/NIDA R01DA002829Aug 1, 1981 - Jun 30, 1993
    Role: Principal Investigator
    DRUG DEPENDENCE CLINICAL RESEARCH PROGRAM
    NIH/NIDA P50DA001696Feb 1, 1978 - Aug 31, 2000
    Role: Principal Investigator
    NEUROPSYCHOPHARMACOLOGY OF ALTERED CONSCIOUSNESS
    NIH/NIDA K05DA000053Jul 1, 1977 - Jun 30, 2009
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Herbst ED, Harris DS, Everhart ET, Mendelson J, Jacob P, Jones R. Cocaethylene formation following ethanol and cocaine administration by different routes. Exp Clin Psychopharmacol. 2011 Apr; 19(2):95-104. PMID: 21463066.
      View in: PubMed
    2. Harris DS, Everhart T, Jacob P, Lin E, Mendelson JE, Jones R. A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. BMC Clin Pharmacol. 2009; 9:13. PMID: 19646280; PMCID: PMC2731040.
      View in: PubMed, PubMed Central
    3. Mendelson JE, McGlothlin D, Harris DS, Foster E, Everhart T, Jacob P, Jones R. The clinical pharmacology of intranasal l-methamphetamine. BMC Clin Pharmacol. 2008; 8:4. PMID: 18644153; PMCID: PMC2496900.
      View in: PubMed, PubMed Central
    4. Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones R. Human pharmacology of the methamphetamine stereoisomers. Clin Pharmacol Ther. 2006 Oct; 80(4):403-20. PMID: 17015058.
      View in: PubMed
    5. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones R. Repeated psychological stress testing in stimulant-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun; 29(5):669-77. PMID: 15913869.
      View in: PubMed
    6. Uemura N, Nath RP, Harkey MR, Henderson GL, Mendelson J, Jones R. Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. J Anal Toxicol. 2004 May-Jun; 28(4):253-9. PMID: 15189676.
      View in: PubMed
    7. Harris DS, Mendelson JE, Lin ET, Upton RA, Jones R. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Clin Pharmacokinet. 2004; 43(5):329-40. PMID: 15080765.
      View in: PubMed
    8. Harris DS, Everhart ET, Mendelson J, Jones R. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003 Nov 24; 72(2):169-82. PMID: 14636972.
      View in: PubMed
    9. Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones R. The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther. 2003 Nov; 74(5):475-86. PMID: 14586388.
      View in: PubMed
    10. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones R. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology. 2003 Sep; 28(9):1677-84. PMID: 12813474.
      View in: PubMed
    11. Mendelson J, Jones R. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment? Drug Alcohol Depend. 2003 May 21; 70(2 Suppl):S29-37. PMID: 12738348.
      View in: PubMed
    12. Jones R. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002 Nov; 42(11 Suppl):58S-63S. PMID: 12412837.
      View in: PubMed
    13. Lester L, Uemura N, Ademola J, Harkey MR, Nath RP, Kim SJ, Jerschow E, Henderson GL, Mendelson J, Jones R. Disposition of cocaine in skin, interstitial fluid, sebum, and stratum corneum. J Anal Toxicol. 2002 Nov-Dec; 26(8):547-53. PMID: 12501911.
      View in: PubMed
    14. Jacob P, Wilson M, Yu L, Mendelson J, Jones R. Determination of 4-hydroxy-3-methoxyphenylethylene glycol 4-sulfate in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem. 2002 Oct 15; 74(20):5290-6. PMID: 12403583.
      View in: PubMed
    15. Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones R. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 2002 Aug; 162(4):396-405. PMID: 12172693.
      View in: PubMed
    16. Delucchi KL, Batki SL, Moon J, Jacob P, Jones R. Urine toxicology samples in cocaine treatment trials: how many need to be tested? J Addict Dis. 2002; 21(2):17-26. PMID: 11916369.
      View in: PubMed
    17. Hall SM, Tunstall CD, Ginsberg D, Benowitz NL, Jones R. Nicotine gum and behavioral treatment: a placebo controlled trial. J Consult Clin Psychol. 1987 Aug; 55(4):603-5. PMID: 3624619.
      View in: PubMed
    Reese's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (112) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (9) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    Back to TOP